• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌中的卡介苗预防可导致募集的中性粒细胞活化。

BCG prophylaxis in bladder cancer produces activation of recruited neutrophils.

作者信息

Vita Francesca, Siracusano Salvatore, Abbate Rita, Ciciliato Stefano, Borelli Violetta, Soranzo Maria Rosa, Zabucchi Giuliano

机构信息

Department of Physiology, University of Trieste, Italy.

出版信息

Can J Urol. 2011 Feb;18(1):5517-23.

PMID:21333042
Abstract

INTRODUCTION

Bacillus Calmette-Guerin (BCG) is used to treat high risk superficial bladder cancer, but its anti-tumor effect remains incompletely defined. Recently a role for polymophonuclear (PMN) neutrophils has been suggested. To investigate the role of granulocytes, we monitored the activation state of these cells in the urine of BCG-treated patients.

MATERIALS AND METHODS

Ten patients with stage T1, grade 3 (T1G3) transitional cell carcinoma received an 8 week course of BCG after undergoing transurethral resection of the bladder. Cytological and enzymatic analyses of urine samples collected before and 2 hours after the physiological expulsion of BCG were performed. The activation state of urine granulocytes and the presence of activating factors within the urine samples were monitored.

RESULTS

BCG immunotherapy stimulated, through soluble factors, the activation of PMN neutrophils, which transmigrated into the bladder, and the degree of activation of the PMN neutrophils was related directly to the number of epithelial cells detached from the urothelial layer.

CONCLUSIONS

This study suggests that PMN neutrophils can participate in reducing the recurrence of bladder cancer by promoting urothelial cell turnover proportionally to their degree of activation. Our results provide further evidence to support the role of PMN neutrophils in BCG immunotherapy.

摘要

引言

卡介苗(BCG)用于治疗高危浅表性膀胱癌,但其抗肿瘤作用仍未完全明确。最近有研究表明多形核(PMN)中性粒细胞发挥了作用。为了研究粒细胞的作用,我们监测了卡介苗治疗患者尿液中这些细胞的激活状态。

材料与方法

10例T1期3级(T1G3)移行细胞癌患者在接受经尿道膀胱切除术后接受了为期8周的卡介苗治疗。对卡介苗自然排出前和排出后2小时收集的尿液样本进行细胞学和酶学分析。监测尿液粒细胞的激活状态以及尿液样本中激活因子的存在情况。

结果

卡介苗免疫疗法通过可溶性因子刺激PMN中性粒细胞的激活,这些中性粒细胞迁移至膀胱,并且PMN中性粒细胞的激活程度与从尿路上皮层脱落的上皮细胞数量直接相关。

结论

本研究表明,PMN中性粒细胞可通过按其激活程度促进尿路上皮细胞更新来参与降低膀胱癌的复发率。我们的结果为支持PMN中性粒细胞在卡介苗免疫疗法中的作用提供了进一步的证据。

相似文献

1
BCG prophylaxis in bladder cancer produces activation of recruited neutrophils.膀胱癌中的卡介苗预防可导致募集的中性粒细胞活化。
Can J Urol. 2011 Feb;18(1):5517-23.
2
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.膀胱肿瘤浸润成熟树突状细胞和巨噬细胞作为卡介苗免疫治疗反应的预测指标
Eur Urol. 2009 Jun;55(6):1386-95. doi: 10.1016/j.eururo.2009.01.040. Epub 2009 Feb 3.
3
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder.中性粒细胞和 TNF 相关凋亡诱导配体 (TRAIL) 在卡介苗(BCG)免疫治疗膀胱尿路上皮癌中的作用。
Cancer Metastasis Rev. 2009 Dec;28(3-4):345-53. doi: 10.1007/s10555-009-9195-6.
4
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.卡介苗维持免疫疗法用于复发性TA、T1期及原位膀胱移行细胞癌:西南肿瘤协作组的一项随机研究
J Urol. 2000 Apr;163(4):1124-9.
5
An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.他汀类药物使用对卡介苗治疗膀胱移行细胞癌疗效的影响分析。
J Urol. 2008 Oct;180(4):1297-300; discussion 1300. doi: 10.1016/j.juro.2008.06.034. Epub 2008 Aug 15.
6
Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.中性粒细胞是卡介苗有效免疫治疗膀胱癌并协调局部免疫反应所必需的。
Cancer Res. 2006 Aug 15;66(16):8250-7. doi: 10.1158/0008-5472.CAN-06-1416.
7
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况:丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.
8
Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.经尿道切除浅表性膀胱癌后卡介苗的免疫预防性膀胱内应用。
Croat Med J. 2003 Apr;44(2):187-92.
9
Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.尿白细胞介素-8和18可预测浅表性膀胱癌对卡介苗膀胱内灌注治疗的反应。
J Urol. 2000 Dec;164(6):2129-33.
10
Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.一项比较卡介苗和表柔比星作为浅表性膀胱癌辅助治疗的随机前瞻性试验的12年随访
Int J Urol. 2005 May;12(5):449-55. doi: 10.1111/j.1442-2042.2005.01064.x.

引用本文的文献

1
Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors.含融合基因BFNA的重组卡介苗对EB病毒阳性肿瘤的抑制作用。
Appl Microbiol Biotechnol. 2025 Jun 3;109(1):134. doi: 10.1007/s00253-025-13528-9.
2
Optimization of BCG Therapy Targeting Neutrophil Extracellular Traps, Autophagy, and miRNAs in Bladder Cancer: Implications for Personalized Medicine.卡介苗疗法针对膀胱癌中性粒细胞胞外诱捕网、自噬和微小RNA的优化:对个性化医疗的启示
Front Med (Lausanne). 2021 Sep 30;8:735590. doi: 10.3389/fmed.2021.735590. eCollection 2021.
3
Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial.
丝裂霉素联合卡介苗序贯膀胱灌注治疗非肌层浸润性尿路上皮膀胱癌:转化研究与I期临床试验
Clin Cancer Res. 2015 Jan 15;21(2):303-11. doi: 10.1158/1078-0432.CCR-14-1781. Epub 2014 Nov 25.